AI discoverability and product line extensions share the same root problem: misclassification kills outcomes before execution even begins.
Most life science companies are optimising the wrong thing - and paying for it twice. In this episode, Matt and Jasmine expose two pressure patterns that product managers and marketers recognise immediately but rarely diagnose correctly: AI visibility that depends on brand signals most companies don't have, and line extension labels applied for political convenience rather than classification accuracy.
This episode is for life science marketers and product managers navigating AI-driven discovery, stage gate processes, and the uncomfortable conversations that live upstream of both.
Key idea: Whether you are building AI discoverability or launching a new product, the classification decision is the fault line - not the execution that follows from it.
[00:42] Introduction
[01:14] AI citation: why brand search volume beats content quality
[05:25] The entity consistency fix most companies haven't done
[07:38] Agents, content operating systems, and the compounding content programme
[09:20] Brand override and word of mouth in an AI-mediated world
[10:25] The line extension trap - who pays when the label is wrong
[12:43] The triad framework: who, how, and what
[15:03] Making the deployment gap concrete enough to fund
[17:29] What to do when leadership won't listen - yet
[20:41] Is this a skills problem or a structural failure?
[22:06] Continuous improvement of the process, not just the product
[23:10] Close
Keywords: AI discoverability, AEO life science, entity consistency, brand search volume, line extension misclassification, stage gate, product manager, life science marketing, GEO content, AI citation